Target intelligence / Profile preview

Defensin beta 108D (DEFB108D)

Target: DEFB108D
Molecular classification: Other (Pseudogene)

Overview

Defensin beta 108D (DEFB108D) is a pseudogene in the beta-defensin family. Beta-defensins are small, cationic peptides with antimicrobial activities and roles in innate immune defense, but DEFB108D is classified as a pseudogene without evidence of encoding a functional protein[1]. While beta-defensins in general can play roles in host immunity and antimicrobial activity[2][3][4][5][7][8], there is no evidence linking DEFB108D to a known biological function, disease process, or therapeutic intervention in humans[1].

Other names: DEFB108DDefensin Beta 108D Pseudogene

Beyond the preview

Go deeper on Defensin beta 108D (DEFB108D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defensin beta 108D (DEFB108D).

Explore the full profile